🇺🇸 FDA
Patent

US 9403792

Methods of using pyruvate kinase activators

granted A61KA61K31/4704A61K31/495

Quick answer

US patent 9403792 (Methods of using pyruvate kinase activators) held by Agios Pharmaceuticals, Inc. expires Mon Jul 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Agios Pharmaceuticals, Inc.
Grant date
Tue Aug 02 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
42
CPC classes
A61K, A61K31/4704, A61K31/495, A61K31/496, A61K31/5025